Labema
Labema Oy is a privately held Finnish life-science distributor, founded in 1988, that imports and supplies diagnostic instruments and laboratory products from international manufacturers to healthcare, food-industry, research, and workplace-testing customers across Finland and the Baltic states.
- Company typePrivate
- Founded1988
- HeadquartersHelsinki, Finland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Labema does
Labema Oy is a Helsinki-based life-science and biotechnology distributor founded in 1988 that imports, markets, and supplies diagnostic instruments and laboratory products to customers in Finland, Estonia, Lithuania, and Latvia. The company's product portfolio spans microbiological culture media (CHROMagar chromogenic media, Neogen Petrifilm plates, culture powders and supplements), clinical diagnostics (Savyon serology kits for Chlamydia, Mycoplasma, and Pertussis; R-Biopharm RIDASCREEN ELISA and RIDAGENE PCR assays; Prolex streptococcus grouping), molecular biology reagents, hygiene and ATP-bioluminescence monitoring, substance-abuse testing (DrugWipe, Kasto urine panels, AlcoQuant breathalyzers), and automated instrumentation (most notably the CE-IVDR-certified Q-linea ASTar antimicrobial susceptibility testing system). Approximately ten international manufacturers rely on Labema as their regional channel, granting territorial distribution rights that constitute the company's primary economic asset.
The business operates a B2B distribution model with revenue generated through one-time product sales of consumables, reagents, and instruments to hospitals, clinical laboratories, food-production companies, research institutions, and workplace-testing customers. Pricing is quote-based and channelled through an online customer portal (Tilaajapalvelu), with order history and standing-order functionality for registered business accounts. Marketing is conducted via the corporate website, a LinkedIn corporate page (Labema Group), and an email newsletter. The company holds CE-IVD, CE-IVDR, and GDPR certifications and operates under its suppliers' ISO 13485 quality systems, positioning it to handle regulated in-vitro diagnostic devices across the EU regulatory perimeter. Headcount sits in the 11-50 band, consistent with a privately held specialty distributor rather than a scaled regional rollup.
Labema firmographics
Firmographics- Name
- Labema
- Legal name
- Labema Oy
- Website
- https://labema.fi
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Labema Oy is a privately held Finnish life-science distributor, founded in 1988, that imports and supplies diagnostic instruments and laboratory products from international manufacturers to healthcare, food-industry, research, and workplace-testing customers across Finland and the Baltic states.
- Ownership category
- akta.pro rank
Labema industry classification
Industry- Product category
- Laboratory Diagnostic Product Distribution
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (33911)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI)
- akta.pro secondary industry
- Lab Safety, PPE & Contamination Control (Hoods, Biosafety Cabinets, Clean Air) (HLAGAIAK)
Keywords
Where Labema is headquartered
LocationHeadquarters
- HQ city
- Helsinki
- HQ country
- Finland
- HQ region
- Europe
Offices1 record
Markets served
Labema business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Product Distribution and Import: Labema operates as a distributor and importer of high-quality diagnostic instruments and laboratory products for healthcare, industry, and research. The company imports, markets and delivers diagnostic products from international manufacturers to Finnish and Baltic markets.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Labema product offering
Product offeringCore offering
Labema Oy imports, markets, and supplies diagnostic instruments and laboratory products for healthcare, industry, and research sectors in Finland and the Baltic states. The company acts as an authorized distributor for international manufacturers including Q-linea, CHROMagar, R-Biopharm, Savyon Diagnostics, Neogen/Megazyme, and Securetec, offering microbiological culture media, rapid diagnostic tests, ELISA/PCR kits, drug screening panels, breathalyzers, and automated antimicrobial susceptibility systems.
Product overview
Labema is a Finnish Life Science and biotechnology expert company founded in 1988 that imports, markets, and supplies high-quality diagnostic instruments and laboratory products for healthcare, industry, and research. The product portfolio is organized into specialized areas including microbiological culture (CHROMagar, Petrifilm plates, culture media powders and supplements), clinical diagnostics (ELISA tests, rapid tests, serology for Chlamydia, Mycoplasma, Pertussis), molecular biology (PCR/reagent tests from RIDA/GENE), drug and alcohol testing (DrugWipe, Kasto panels, AlcoQuant breathalyzers), self-monitoring and hygiene (ATP testing, surface tests), food diagnostics, and research products. The company serves as a distributor for multiple international manufacturers including Neogen, CHROMagar, Savyon Diagnostics, R-Biopharm AG, Q-linea, Medical Wire & Equipment, and Securetec. Key product lines include the ASTar automated antimicrobial susceptibility system, comprehensive sample collection systems, and a wide range of chromogenic culture media.
Differentiator
Problem solved
Functional benefit
Products and services
- AlcoQuant 6020 Breathalyzer
Companies that use Labema
Customer profileSegments4 records
Ideal customer profiles4 records
Labema technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature3 records
Labema partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Q-linea ABcoreLabema Oy has a distribution agreement with Swedish Q-linea AB for Finland and the Baltic region. This partnership expands Labema's sepsis diagnostics portfolio with Q-linea's fully automated ASTar system and BC G-kit, which provides antimicrobial susceptibility results from positive blood cultures in 6 hours for 14 gram-negative bacteria.
- Neogen / MegazymecoreLabema distributes Neogen's Megazyme product range, which includes the complete Megazyme product portfolio for food and beverage analysis, enzyme testing, and carbohydrate analysis.
- CHROMagarcoreLabema is the authorized distributor for CHROMagar products in Finland, Estonia, Lithuania, and Latvia. CHROMagar produces innovative chromogenic culture media for microbiology applications including Candida species differentiation, C. difficile detection, and enteric bacteria identification.
- R-Biopharm AGcoreLabema distributes R-Biopharm AG products in Finland. R-Biopharm is a leading developer of clinical diagnostics and food/feed analysis solutions, offering ELISA, PCR, lateral flow tests, and blot tests.
- Savyon Diagnostics Ltd.coreLabema distributes Savyon Diagnostics products including clinical diagnostic tests for Chlamydia, Mycoplasma pneumoniae, Bordetella pertussis, and other pathogens. Product range includes SeroFIA, SeroCP, SeroMP, and QuickStripe rapid test platforms.
- Medical Wire & EquipmentminorLabema distributes Medical Wire & Equipment products including Transwab collection and transport systems, Sigma collection devices, and specimen collection products for microbiology applications.
- ELITech (part of Bruker)minorLabema distributes ELITech products in Finland for clinical chemistry, microbiology, and hematology applications. Products include sweat chloride analyzers and slide stainers.
- Microbiologics Inc.minorLabema distributes Microbiologics quality control organisms for clinical, food, and environmental laboratories, as well as pharmacy and industrial applications.
- Securetec Detektions-Systeme AGminorLabema distributes Securetec DrugWipe rapid tests for substance abuse detection from saliva, sweat, and surfaces. Founded in 1995, Securetec develops technology for drug and hazardous substance detection for occupational safety and healthcare.
- Pro-Lab Diagnostics UKminorLabema distributes Pro-Lab Diagnostics products including Prolex Blue Strep kits for Lancefield grouping of beta-hemolytic streptococci.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
Labema competitors and assessment
Company assessmentDirect peers
- AH Diagnostics: Danish distributor of diagnostic and laboratory products serving the Nordic market with a multi-principal portfolio spanning clinical microbiology, molecular diagnostics, and food safety. Closely mirrors Labema's customer verticals and partner-driven distribution model.
- BioNordika: Stockholm-based distributor of life science and diagnostic products across the Nordics. Directly comparable to Labema as a regional specialty distributor offering microbiology, molecular biology, and clinical diagnostics solutions from multiple international manufacturers.
- Stratech Scientific: UK-based distributor of life science and diagnostic reagents and instruments. Comparable to Labema through its multi-principal specialty distribution model covering ELISA, PCR, microbiology, and clinical diagnostics consumables.
- Alpha Laboratories: UK-based specialist distributor of clinical diagnostics, laboratory, and life science consumables. Comparable to Labema as a focused multi-principal distributor serving hospital and clinical laboratory customers.
Regional players
- Sarstedt: German manufacturer and direct distributor of laboratory and medical products with established Nordic presence. Overlaps Labema in sample collection, transport systems, and laboratory consumables for clinical and research customers.
Broad incumbents
- Merck Life Science (Sigma-Aldrich): Global supplier of life science products including microbiology media, molecular biology reagents, and laboratory consumables. Competes with Labema in the same Nordic-Baltic accounts with significantly broader catalog depth.
- Bio-Rad Laboratories: Global manufacturer and distributor of clinical diagnostics and life science research products with strong presence in microbiology and molecular biology reagents. Overlaps Labema's culture media, ELISA, and QC organism lines as a broader incumbent.
- Thermo Fisher Scientific: Global life science and diagnostics leader with direct Nordic-Baltic sales coverage and a catalog that overlaps Labema's entire range (microbiological media, ELISA, PCR, hygiene). Competes with Labema primarily on breadth and direct account access with large hospital systems.
- Avantor (VWR): Global distributor of laboratory products and services serving pharmaceutical, biotech, healthcare, and food customers. Competes with Labema across lab consumables, microbiology, and clinical diagnostics categories with broader geographic reach.
Others
- Starlab International: European manufacturer and supplier of laboratory consumables including pipette tips, tubes, and culture-related products. Comparable as an adjacent supplier into Labema's same customer segments but operating in different product categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Labema social profiles
Digital presenceLabema compliance and trust
Trust signalCompliance4 records
Labema financial estimates
Financial estimateRevenue estimate
Valuation estimate
Labema leadership team
Management profileNumber of profiles
Profiles5 records
Labema funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Labema M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Labema
What does Labema do?
Labema Oy imports, markets, and supplies diagnostic instruments and laboratory products for healthcare, industry, and research sectors in Finland and the Baltic states. The company acts as an authorized distributor for international manufacturers including Q-linea, CHROMagar, R-Biopharm, Savyon Diagnostics, Neogen/Megazyme, and Securetec, offering microbiological culture media, rapid diagnostic tests, ELISA/PCR kits, drug screening panels, breathalyzers, and automated antimicrobial susceptibility systems.
Is Labema a public or private company?
Labema is a private company. It is classified as unknown and is currently operating.
When was Labema founded?
Labema was founded in 1988. It employs 11 to 50 people.
Where is Labema based?
Labema is headquartered in Helsinki, Finland, in the Europe region.
How does Labema make money?
One revenue line is on record: product Distribution and Import.
Who are Labema's main competitors?
Direct peers on record are AH Diagnostics, BioNordika, Stratech Scientific and Alpha Laboratories. Sarstedt is listed as a regional player. Broad incumbents are Merck Life Science (Sigma-Aldrich), Bio-Rad Laboratories, Thermo Fisher Scientific and Avantor (VWR). Starlab International is listed as an others.
Does Labema have an API?
No public API is recorded for Labema.
What industry is Labema in?
Labema's product category is Laboratory Diagnostic Product Distribution. Its primary akta.pro industry code is HLAAAKAI, Raw Materials & Critical Reagents Supply Services (media, resins, single-use), with a secondary code of HLAGAIAK, Lab Safety, PPE & Contamination Control (Hoods, Biosafety Cabinets, Clean Air). Its NAICS code is 325413 and its SIC code is 5047.